GEHC vs ZTS — Key Metrics
| Metric | GEHC (GE HEALTHCARE TECHNOLOGIES INC) | ZTS (ZOETIS INC) |
|---|---|---|
| Price | 65.37 | 69.83 |
| Market Cap | 29.53 Billion | 28.86 Billion |
| P/E (TTM) | 14.99 | 11.49 |
| P/B (Quarterly) | 2.959 | 10.143 |
| P/S (TTM) | 1.39 | 3.03 |
| Net Profit Margin (TTM) | 9.3 | 27.5 |
| Gross Margin (TTM) | 39.5 | 71.5 |
| ROE (TTM) | 18.9 | 69.3 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
GEHC · GE HEALTHCARE TECHNOLOGIES INC
Outperform
ZTS · ZOETIS INC
Greatly Outperform
Recommendation Summary
Stock GEHC is projected to outperform the market, stock ZTS is projected to greatly outperform the market. Upfront Recommendation: ZTS.
Financial Metrics
Prices delayed ~15 min
| GEHC | Metrics | ZTS |
|---|---|---|
| $65.37 | Price | $69.83 |
| — | Market Capitalization | — |
| 14.99 | Price to Earnings Ratio | 11.49 |
| 1.39 | Price to Sales | 3.03 |
| 18.7 | Price to FCF Ratio | 12.14 |
| 3.51 | Price to Gross Profit | 4.24 |
| 23.01 | Price to R&D | 39.97 |
| 2.81 | Price to Current Assets | 4.54 |